Latest Margin Expansion News

Trajan Group Holdings has reported record FY25 revenue of $166.5 million, exceeding guidance despite operational headwinds. However, EBITDA fell slightly short of forecasts, reflecting challenges in supply chains and market shifts.

Cobalt Blue Holdings reveals promising engineering upgrades and exploration success at its Halls Creek Project, targeting enhanced margins and extended mine life through silver recovery, cobalt credits, and new copper discoveries.

Duratec Limited has acquired EIG Australia for up to $9 million, significantly boosting its fuel infrastructure and electrical services capabilities across key Australian sectors including Defence and Mining.

SKS Technologies Group has exceeded its FY25 profit guidance, reporting a 15.6% increase in profit before tax alongside robust revenue growth and a strong cash position.

8common Limited has closed FY25 with a positive operational cash flow and EBITDA, driven by record SaaS revenue and significant margin improvements following major infrastructure upgrades.

Althea Group Holdings reported significant cash outflows in Q2 2025 due to one-off costs but anticipates operational improvements and revenue growth from its North American business units.

Wellnex Life Limited reported a robust Q4 FY25 with a 22% sales increase and positive operational cash flow, underpinning its strategic growth initiatives backed by new debt funding.

Swift Networks reports positive FY25 cash flow and EBITDA, secures new mining contracts, and progresses its next-generation Swift Access 2026 platform poised to accelerate growth.

Next Science reports a 10% decline in quarterly product sales but advances a $50 million asset sale to Demetra Holdings, signaling a pivotal shift in its business strategy.

Eneco Refresh Limited reported a solid 7% revenue increase in Q4 FY25, driven by strong regional performances and renewed contracts, while investing in automation and operational efficiency.

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 amid promising regulatory and market developments.

De.mem Limited has reported its second highest quarterly cash receipts ever, alongside a fourth consecutive quarter of positive operating cash flow, positioning the company for a record full-year 2025 performance.